How Electronic Data Collection Helps Meet the FDA's Quality Guidelines

April 15, 2016

Offering guidance for generating strong evidence in clinical research, the acronym "ALCOA" is widely used to outline the FDA's fundamental elements of quality for clinical data. 

CRF Health VP of Quality Assurance, Bob Murray, details the individual components of ALCOA and describes how capturing clinical outcomes data electronically helps trial sponsors meet and exceed each guideline.

Previous
eCOA Impact on Data Quality
eCOA Impact on Data Quality

Next
The Importance of eCOA User Experience Design
The Importance of eCOA User Experience Design

Webinar: 5 Best Practices for Using Connected Devices in Clinical Trials

Register Now